Stay updated on Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial
Sign up to get notified when there's something new on the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page.

Latest updates to the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated to version 2.16.0, replacing the previous version 2.15.2.SummaryDifference0.1%
- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.0%
- Check43 days agoChange DetectedThe page has been updated to include new drug classifications related to diabetes treatment, specifically mentioning meglitinides, SGLT-2 inhibitors, sulphonylureas, and thiazolidinediones. Additionally, the revision number has been updated from v2.14.4 to v2.15.0.SummaryDifference6%
- Check57 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check64 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check101 days agoChange DetectedThe web page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference0.7%
Stay in the know with updates to Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Efficacy Comparison: Victoza vs. OADs in T2D Clinical Trial page.